Cargando…
High bone turnover and hyperparathyroidism after surgery for tumor-induced osteomalacia: A case series
Tumor-induced osteomalacia (TIO) is an ultrarare disorder that is caused by renal phosphate wasting due to uncontrolled tumoral production of fibroblast growth factor 23 (FGF23) from phosphaturic mesenchymal tumors. Surgical removal of the tumor is curative. There is limited information on the bioch...
Autores principales: | Kilbane, Mark T., Crowley, Rachel, Heffernan, Eric, D'Arcy, Clare, O'Toole, Gary, Twomey, Patrick J., McKenna, Malachi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640873/ https://www.ncbi.nlm.nih.gov/pubmed/34901333 http://dx.doi.org/10.1016/j.bonr.2021.101142 |
Ejemplares similares
-
Renal Phosphate Handling: Independent Effects of Circulating FGF23, PTH, and Calcium
por: McKenna, Malachi J, et al.
Publicado: (2020) -
Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report
por: Crowley, Rachel K, et al.
Publicado: (2014) -
COVID-19 pandemic and vitamin D: rising trends in status and in daily amounts of vitamin D provided by supplements
por: McKenna, Malachi J, et al.
Publicado: (2022) -
The impact of diet, body composition, and physical activity on child bone mineral density at five years of age—findings from the ROLO Kids Study
por: McVey, Marco K., et al.
Publicado: (2019) -
Multiple Looser zones of osteomalacia in Byler disease with associated vitamin D deficiency, phosphaturia, and elevated FGF23
por: Tarazi, M., et al.
Publicado: (2015)